Orbital syndromes

Seminars in Neurology

Volumn 27, Issue 3, 2007, Pages 269-287

  Bhatti, M Tariq ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Carotid cavernous sinus fistula; Cutaneous squamous cell carcinoma; Graves' disease; Mucormycosis; Orbit; Perineural tumor spread; Proptosis; Thyroid associated orbitopathy

Indexed keywords

ANAMNESIS; CAROTID CAVERNOUS FISTULA; CLINICAL EVALUATION; ENDOCRINE OPHTHALMOPATHY; MUCORMYCOSIS; ORBIT DISEASE; ORBIT INFLAMMATION; ORBIT PSEUDOTUMOR; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

CRANIAL NERVES; HUMANS; OPHTHALMIC ARTERY; ORBIT; ORBITAL DISEASES;

EID: 34347344975     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979685     Document Type: Review

References (90)

1. Wilson MW, Grossniklaus HE. Orbital disease in North America. Ophthalmol Clin North Am 1996;9:539-547
2. Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. Philadelphia: Lippincott Williams & Wilkins; 2003
3. Doxanas MT, Anderson RL. Clinical Orbital Anatomy. Baltimore: Williams & Wilkins; 1984
4. Rhoton AL, Natori Y. The Orbit and Sellar Region: Microsurgical Anatomy and Operative Approaches. New York: Thieme Medical Publishers; 1996
5. Rootman J, Stewart B, Goldberg RA. Orbital Surgery: A Conceptual Approach. Philadelphia: Lippincott-Raven Publishers; 1995
6. Hayek G, Mercier P, Fournier HD. Anatomy of the orbit and its surgical approach. Adv Tech Stand Neurosurg 2006; 31:35-71
7. Cheung N, McNab AA. Venous anatomy of the orbit. Invest Ophthalmol Vis Sci 2003;44:988-995
8. Otto CS, Coppit GL, Mazzoli RA, et al. Gaze-evoked amaurosis: a report of five cases. Ophthalmology 2003;110: 322-326
9. Cline RA, Rootman J. Enophthalmos: a clinical review. Ophthalmology 1984;91:229-237
10. Chang BY, Cunniffe G, Hutchinson C. Enophthalmos associated with primary breast carcinoma. Orbit 2002;21: 307-310
11. Kupersmith MJ. Neuro-Vascular Neuro-Ophthalmology. Berlin: Springer-Verlag; 1993
12. Coday MP, Netland PA, Dallow RL. Thyroid-associated ophthalmolopathy (Graves' disease). In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol. 5. Philadelphia: WB Saunders Company; 2000:4742-4759
13. Chang EL, Rubin PA. Upper and lower eyelid retraction. Int Ophthalmol Clin 2002;42:45-59
14. Gaymard B, Huynh C, Laffont I. Unilateral eyelid retraction. J Neurol Neurosurg Psychiatry 2000;68:390-392
15. Yeh S, Foroozan R. Orbital apex syndrome. Curr Opin Ophthalmol 2004;15:490-498
16. Ettl A, Salomonowitz E, Koornneef L, Zonneveld FW. High-resolution MR imaging anatomy of the orbit: correlation with comparative cryosectional anatomy. Radiol Clin North Am 1998;36:1021-1045 ix
17. Aviv RI, Miszkiel K. Orbital imaging: part 2. Intraorbital pathology. Clin Radiol 2005;60:288-307
18. Herrick RC, Hayman LA, Taber KH, Diaz-Marchan PJ, Kuo MD. Artifacts and pitfalls in MR imaging of the orbit: a clinical review. Radiographics 1997;17:707-724
19. Belden CJ, Zinreich SJ. Orbital imaging techniques. Semin Ultrasound CT MR 1997;18:413-422
20. Simon J, Szumowski J, Totterman S, et al. Fat-suppression MR imaging of the orbit. AJNR Am J Neuroradiol 1988;9: 961-968
21. Barakos JA, Dillon WP, Chew WM. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging. Radiology 1991;179:191-198
22. Lieb WE. Color Doppler imaging of the eye and orbit. Radiol Clin North Am 1998;36:1059-1071
23. Chen CC, Chang PC, Shy CG, Chen WS, Hung HC. CT angiography and MR angiography in the evaluation of carotid cavernous sinus fistula prior to embolization: a comparison of techniques. AJNR Am J Neuroradiol 2005;26:2349-2356
24. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993;329:1468-1475
25. Gorman CA. Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983;58:515-519
26. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21:168-199
27. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 2002;120:380-386
28. Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 2006;142:147-153
29. Volpe NJ, Sbarbaro JA, Gendron Livingston K, Galetta SL, Liu GT, Balcer LJ. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography. Am J Ophthalmol 2006;142:75-81
30. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:284-290
31. Peyster RG, Ginsberg F, Silber JH, Adler LP. Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. AJR Am J Roentgenol 1986;146:459-464
32. Dallow RL, Netland PA. Management of thyroid-associated orbitopathy (Graves' disease). In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol. 4. Philadelphia: WB Saunders Company; 2000:3082-3099
33. Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol 1996;41:66-78
34. Snebold NG. Noninfectious orbital inflammations and vasculitis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol. 4. Philadelphia: WB Saunders Company; 2000:3100-3121
35. Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit: clinical, pathologic, and radiologic evaluation. Radiol Clin North Am 1999;37:151-168
36. Mahr MA, Salomao DR, Garrity JA. Inflammatory orbital pseudotumor with extension beyond the orbit. Am J Ophthalmol 2004;138:396-400
37. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 1996; 103:521-528
38. Kline LB, Hoyt WF. The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry 2001;71:577-582
39. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491-499
40. Rootman J, Nugent R. The classification and management of acute orbital pseudotumors. Ophthalmology 1982;89:1040-1048
41. Weissler MC, Miller E, Fortune MA. Sclerosing orbital pseudotumor: a unique clinicopathologic entity. Ann Otol Rhinol Laryngol 1989;98:496-501
42. Bernardino CR, Davidson RS, Maus M, Spaeth GL. Angle-closure glaucoma in association with orbital pseudotumor. Ophthalmology 2001;108:1603-1606
43. Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: clinical and radiographic features. Arch Ophthalmol 2001; 119:1299-1306
44. McKinnon SG, Gentry LR. Systemic diseases involving the orbit. Semin Ultrasound CT MR 1998;19:292-308
45. Weber AL, Jakobiec FA, Sabates NR. Lymphoproliferative disease of the orbit. Neuroimaging Clin N Am 1996;6:93-111
46. Gordon LK. Diagnostic dilemmas in orbital inflammatory disease. Ocul Immunol Inflamm 2003;11:3-15
47. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513
48. Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001;85:1220-1224
49. Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004;138:925-930
50. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992;26:467-484
51. Mohs FE, Lathrop TG. Modes of spread of cancer of skin. AMA Arch Derm Syphilol 1952;66:427-439
52. Cruveilhier J. Maladies des Nerfs: Anatomie Pahologique du Corps Humain. Vol. 2. Paris: Bailliere; 1842:1835-1842
53. Dodd GD, Dolan PA, Ballantyne AJ, Ibanez ML, Chau P. The dissemination of tumors of the head and neck via the cranial nerves. Radiol Clin North Am 1970;8:445-461
54. Veness MJ, Biankin S. Perineural spread leading to orbital invasion from skin cancer. Australas Radiol 2000;44:296-302
55. Smith JB, Bishop VL, Francis IC, Kos S, Kneale KA. Ophthalmic manifestations of perineural spread of facial skin malignancy. Aust NZ J Ophthalmol 1990;18:197-205
56. Clouston PD, Sharpe DM, Corbett AJ, Kos S, Kennedy PJ. Perineural spread of cutaneous head and neck cancer: its orbital and central neurologic complications. Arch Neurol 1990;47:73-77
57. Caldemeyer KS, Mathews VP, Righi PD, Smith RR. Imaging features and clinical significance of perineural spread or extension of head and neck tumors. Radiographics 1998;18:97-110
58. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-990
59. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-983
60. Barksdale SK, O'Connor N, Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma: determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 1997;6:625-638
61. McNab AA, Francis IC, Benger R, Crompton JL. Perineural spread of cutaneous squamous cell carcinoma via the orbit: clinical features and outcome in 21 cases. Ophthalmology 1997;104:1457-1462
62. Bowyer JD, Sullivan TJ, Whitehead KJ, Kelly LE, Allison RW. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg 2003;19:275-281
63. Lawrence N, Cottel WI. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 1994;31:30-33
64. Carter RL, Foster CS, Dinsdale EA, et al. Perineural spread by squamous cell carcinomas of the head and neck: a morphological study using antiaxonal and antimyelin monoclonal antibodies. J Clin Pathol 1983;36:269-275
65. Ginsberg LE. Imaging of perineural tumor spread in head and neck cancer. Semin Ultrasound CT MR 1999;20:175-186
66. Moore CE, Hoyt WF, North JB. Painful ophthalmoplegia following treated squamous carcinoma of the forehead: orbital apex involvement from centripetal spread via the supraorbital nerve. Med J Aust 1976;1:657-659
67. Esmaeli B, Ginsberg L, Goepfert H, Deavers M. Squamous cell carcinoma with perineural invasion presenting as a Tolosa-Hunt-like syndrome: a potential pitfall in diagnosis. Ophthal Plast Reconstr Surg 2000;16:450-452
68. Trobe JD, Hood CI, Parsons JT, Quisling RG. Intracranial spread of squamous carcinoma along the trigeminal nerve. Arch Ophthalmol 1982;100:608-611
69. Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001;49:1061-1069
70. Williams LS. Advanced concepts in the imaging of perineural spread of tumor to the trigeminal nerve. Top Magn Reson Imaging 1999;10:376-383
71. Esmaeli B, Ahmadi MA, Gillenwater AM, Faustina MM, Amato M. The role of supraorbital nerve biopsy in cutaneous malignancies of the periocular region. Ophthal Plast Reconstr Surg 2003;19:282-286
72. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-569
73. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301
74. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22
75. Harril WC, Stewart MG, Lee AG, Cernoch P. Chronic rhinocerebral mucormycosis. Laryngoscope 1996;106:1292-1297
76. Dhiwakar M, Thakar A, Bahadur S. Improving outcomes in rhinocerebral mucormycosis: early diagnostic pointers and prognostic factors. J Laryngol Otol 2003;117:861-865
77. Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L. Mucormycosis: early diagnosis and treatment. Rev Laryngol Otol Rhinol (Bord) 2004;125:127-131
78. Ferry AP, Abedi S. Diagnosis and management of rhinoorbitocerebral mucormycosis (phycomycosis): a report of 16 personally observed cases. Ophthalmology 1983;90:1096-1104
79. Safar A, Marsan J, Marglani O, Al-Sebeih K, Al-Harbi J, Valvoda M. Early identification of rhinocerebral mucormycosis. J Otolaryngol 2005;34:166-171
80. Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004;80:670-674
81. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: changing patterns of disease. Surg Neurol 1994;41:152-156
82. Bodenstein NP, McIntosh WA, Vlantis AC, Urquhart AC. Clinical signs of orbital ischemia in rhino-orbitocerebral mucormycosis. Laryngoscope 1993;103:1357-1361
83. Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997;107:855-862
84. Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg 2006;22:286-291
85. Barrow DL, Spector RH, Braun IF, Landman JA, Tindall SC, Tindall GT. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg 1985;62:248-256
86. Miller NR. Carotid-cavernous sinus fistulas. In: Miller NR, Newman NJ, Biousse V, Kerrison JB, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol. 2. Baltimore: Williams & Wilkins; 2005:2263-2296
87. Bhatti MT, Peters KR. A red eye and then a really red eye. Surv Ophthalmol 2003;48:224-229
88. Keltner JL, Satterfield D, Dublin AB, Lee BC. Dural and carotid cavernous sinus fistulas: diagnosis, management, and complications. Ophthalmology 1987;94:1585-1600
89. Sergott RC, Grossman RI, Savino PJ, Bosley TM, Schatz NJ. The syndrome of paradoxical worsening of dural-cavernous sinus arteriovenous malformations. Ophthalmology 1987;94:205-212
90. Barnwell SL, O'Neill OR. Endovascular therapy of carotid cavernous fistulas. Neurosurg Clin N Am 1994;5:485-495